- Home
- VBIX vs CASI Comparison
VBIX vs CASI Comparison
Compare VBIX & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VBIX
- CASI
- Stock Information
- Founded
- VBIX N/A
- CASI 1991
- Country
- VBIX Israel
- CASI China
- Employees
- VBIX N/A
- CASI N/A
- Industry
- VBIX Computer Software: Prepackaged Software
- CASI Biotechnology: Pharmaceutical Preparations
- Sector
- VBIX Technology
- CASI Health Care
- Exchange
- VBIX Nasdaq
- CASI Nasdaq
- Market Cap
- VBIX 30.9M
- CASI 35.8M
- IPO Year
- VBIX N/A
- CASI 1996
- Fundamental
- Price
- VBIX $2.65
- CASI $2.09
- Analyst Decision
- VBIX
- CASI Strong Buy
- Analyst Count
- VBIX 0
- CASI 1
- Target Price
- VBIX N/A
- CASI $4.00
- AVG Volume (30 Days)
- VBIX 20.0K
- CASI 82.7K
- Earning Date
- VBIX 08-14-2025
- CASI 11-13-2025
- Dividend Yield
- VBIX N/A
- CASI N/A
- EPS Growth
- VBIX N/A
- CASI N/A
- EPS
- VBIX N/A
- CASI N/A
- Revenue
- VBIX $14,620,000.00
- CASI $31,564,000.00
- Revenue This Year
- VBIX N/A
- CASI N/A
- Revenue Next Year
- VBIX N/A
- CASI N/A
- P/E Ratio
- VBIX N/A
- CASI N/A
- Revenue Growth
- VBIX N/A
- CASI 36.64
- 52 Week Low
- VBIX $2.42
- CASI $1.09
- 52 Week High
- VBIX $12.00
- CASI $7.50
- Technical
- Relative Strength Index (RSI)
- VBIX 35.97
- CASI 47.18
- Support Level
- VBIX $2.48
- CASI $2.18
- Resistance Level
- VBIX $2.96
- CASI $2.49
- Average True Range (ATR)
- VBIX 0.28
- CASI 0.18
- MACD
- VBIX 0.05
- CASI -0.05
- Stochastic Oscillator
- VBIX 26.67
- CASI 7.70
About VBIX Viewbix Inc. Common Stock
ViewBix Inc operates in the field of digital advertising. Along with its subsidiaries, the company performs two main activities that are reported as separate operating segments: the search segment and the digital content segment. Maximum revenue is generated from the digital content segment, which is engaged in the creation and editing of content, in different languages, for different target audiences, to generate revenues from advertising platforms, including Google, Facebook, Yahoo, and Apple, by utilizing such content to obtain internet user traffic for its customers. The search segment develops various technological software solutions, which perform automation, optimization, and monetization of internet campaigns, to obtain and route internet user traffic to its customers.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.